ACON

Conviction 0HealthcareScan · Mon, Aug 10, 2026

Bullish engulfing

ACON$2.37+3.49%

ResistanceSupportVol 14Insider buy

Vol MA14 49.6K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Aclarion, Inc.SERVICES-MEDICAL LABORATORIESwww.aclarion.com ↗

Price2.37

Change+3.49%

Gap+0.00%

Rel volume0.68×

Avg volume43.88K

Avg $ vol102.48K

SMA 202.39

SMA 502.81

SMA 2004.01

Price vs 50-15.66%

Price vs 200-40.87%

MA stackbearish

50/200 cross—

Supertrenddown · 2.54

RSI (14)43

MACD hist0.03

MACD crossbull · 4d

Stoch %K / %D60 / 55

ADX (14)27

+DI / −DI18 / 23

RSI divergence—

MACD divergence—

ATR %+7.37%

ADR %6.92%

52w high9.69

52w low2.02

From 52w high-75.54%

Above 52w low+17.62%

New 52w highNo

SqueezeOff

Bollinger width32.72%

%B0.47

Donchian pos49.12%

Donchian high2.81

Donchian low1.95

AVWAP (52w high)7.15

vs AVWAP high-66.83%

AVWAP (52w low)2.26

vs AVWAP low+4.84%

OBV trendDown

Chaikin MF (20)-0.08

Today vs 20d0.68×

Avg vol (14d)49.6K

Avg vol (20d)43.88K

Avg $ vol (20d)102.48K

Market cap—

RS 3m (vs SPY)-33.23%

RS 6m (vs SPY)-17.08%

RS line new highNo

Trend template0/8

Technical rank14.5

1 week+0.42%

1 month-16.67%

3 months-25.59%

6 months-13.82%

1 year-67.58%

YTD-52.41%

P/E-0.90

P/B0.38

P/S86.02

P/FCF-0.91

EPS-13.61

Div yield—

ROE-42.54%

ROA-40.10%

Debt/Eq—

Current16.20

EV/EBITDA1.43

Gross margin9.02%

Net margin—

Rev growth65.62%

EPS growth-3.44%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-9.77M

Revenue25.21K

Net income-2.75M

Gross profit8.3K

Free cash flow-7.19M

IndustrySERVICES-MEDICAL LABORATORIES

ExchangeNasdaq

Shares out2.46M

Employees11

ListedFri, Apr 22, 2022

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank14.5 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACON

All disclosures →

No recent disclosed trades by Congress in ACON. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACON · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Deitsch Stephen Director · Common Stock · 2026-06-11	Grant	20K	—	2026-06-11	2026-06-12
Thramann Jeffrey John Executive Chairman · Common Stock · 2026-06-11	Grant	100K	—	2026-06-11	2026-06-12
Neal David K Director · Common Stock · 2026-06-11	Grant	20K	—	2026-06-11	2026-06-12
Wesemann William Director · Common Stock · 2026-06-11	Grant	20K	—	2026-06-11	2026-06-12
Ness Brent Chief Executive Officer · Common Stock · 2026-06-11	Grant	100K	—	2026-06-11	2026-06-12
Breidbart Scott Director · Common Stock · 2026-06-11	Grant	20K	—	2026-06-11	2026-06-12
Gould Gregory A Chief Financial Officer · Common Stock · 2026-06-11	Grant	50K	—	2026-06-11	2026-06-12
Sequira Amanda Mae Director · Common Stock · 2026-06-11	Grant	20K	—	2026-06-11	2026-06-12
Bond Ryan Chief Strategy Officer · Common Stock · 2026-06-11	Grant	55K	—	2026-06-11	2026-06-12
Breidbart Scott Director · Common Stock · 2026-05-12	Buy	5.66K	$18K	2026-05-12	2026-05-12

SEC filings

EDGAR filings in ACON · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.